CTNNA2 Matched Antibody Pair (315) (APMAB-315LY)

Wen, Y., Lin, A., Zhu, W., Wei, T., Luo, P., Guo, L., & Zhang, J. (2021). Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Frontiers in Pharmacology, 12.

Eszlari, N., Bagyura, Z., Millinghoffer, A., Nagy, T., Juhasz, G., Antal, P., ... & Bagdy, G. (2021). Catenin Alpha 2 May Be a Biomarker or Potential Drug Target in Psychiatric Disorders with Perseverative Negative Thinking. Pharmaceuticals, 14(9), 850.

Song, J., Zhang, P., Liu, M., Xie, M., Gao, Z., Wang, X., ... & Liu, R. (2019). Novel-miR-4885 promotes migration and invasion of esophageal Cancer cells through targeting CTNNA2. DNA and cell biology, 38(2), 151-161.

Schaffer, A. E., Breuss, M. W., Caglayan, A. O., Al-Sanaa, N., Al-Abdulwahed, H. Y., Kaymakcalan, H., ... & Gleeson, J. G. (2018). Biallelic loss of human CTNNA2, encoding αN-catenin, leads to ARP2/3 complex overactivity and disordered cortical neuronal migration. Nature genetics, 50(8), 1093-1101.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols